Remodeling of the tumor microenvironment via disrupting Blimp1+ effector Treg activity augments response to anti-PD-1 blockade
Abstract Background Accumulation of Foxp3+ regulatory T (Treg) cells in the tumor often represents an important mechanism for cancer immune evasion and a critical barrier to anti-tumor immunity and immunotherapy. Many tumor-infiltrating Treg cells display an activated phenotype and express the trans...
Guardado en:
Autores principales: | Michael L. Dixon, Lin Luo, Sadashib Ghosh, Jeffrey M. Grimes, Jonathan D. Leavenworth, Jianmei W. Leavenworth |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/30ce81d646da475cb6af87c87c5a8680 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CD4+ effector T cells accelerate Alzheimer’s disease in mice
por: Jatin Machhi, et al.
Publicado: (2021) -
Increased Frequency of CTLA-4 and PD-1 Expressing Regulatory T Cells and Basophils With an Activating Profile in Infants With Moderate-to-Severe Atopic Dermatitis Hypersensitized to Food Allergens
por: Agurtzane Bilbao, et al.
Publicado: (2021) -
The TNF-α/TNFR2 Pathway: Targeting a Brake to Release the Anti-tumor Immune Response
por: Audrey Moatti, et al.
Publicado: (2021) -
Impact of Graft-Resident Leucocytes on Treg Mediated Skin Graft Survival
por: Romy Steiner, et al.
Publicado: (2021) -
“High Treg” Inflammations Promote (Most) Non-Hematologic Cancers While “Low Treg” Inflammations Promote Lymphoid Cancers
por: Elkoshi Z
Publicado: (2020)